Navigation Links
Col. Robert E. Shields Joins Palmetto GBA's Board of Directors
Date:5/20/2008

COLUMBIA, S.C., May 20 /PRNewswire-USNewswire/ -- Palmetto GBA, a leading provider of technical and administrative services for the federal government, announced today that Robert E. Shields, a retired Air Force colonel and former executive with health insurer Humana Inc., has been appointed to serve on its board of directors.

Shields, a resident of Isle of Palms, S.C., retired in 2005 as senior vice president for Louisville, Ky.-based Humana, where he had served as an executive for 11 years. After retiring from the Air Force, Shields served from 1994 to 2000 as CEO of Humana Military Healthcare Services Inc., one of three companies that operate the Department of Defense's TRICARE health care program.

During his distinguished military career, Shields served as Chief of the Air Force Office of the Surgeon General Managed Care Division. Shields is a 1970 graduate of The Citadel, and he holds master's degrees from the University of California and Virginia Commonwealth University.

"Palmetto GBA is indeed fortunate to have someone with the diverse and relevant background, history of accomplishment, and superb leadership skills that Colonel Shields possesses," said Bruce Hughes, president of Palmetto GBA.

Based in Columbia, S.C., Palmetto GBA (http://www.palmettogba.com) is a wholly owned subsidiary of BlueCross BlueShield of South Carolina. Palmetto GBA's principal business is providing administrative services for the Medicare health benefit program. The company has offices in South Carolina, Florida, Georgia, Ohio and Illinois.

Palmetto GBA and BlueCross BlueShield of South Carolina are independent licensees of the Blue Cross and Blue Shield Association, an association of independent Blue Cross and Blue Shield Plans.


'/>"/>
SOURCE Palmetto GBA
Copyright©2008 PR Newswire.
All rights reserved

Page: 1

Related medicine news :

1. Diagnostic Health Corporation Names Robert E. Gontarek as COO
2. PAREXEL International to Present at Robert W. Bairds 2008 Growth Stock Conference
3. Harvard Business School Publishes a Case Study on Robert Wessman and Actavis
4. Robert Wood Johnson Foundation Partners with AACN to Launch New Careers in Nursing Scholarship Program
5. UT Southwestern Medical Center receives grant from the Robert Wood Johnson Foundation
6. More Than 1,000 Childrens Memorial Hospital Patients, Physicians, Elected Officials, Donors and Staff Gather to Break Ground on the Ann & Robert H. Lurie Childrens Hospital of Chicago
7. Sen. Robert Byrd Receives AOA Health Care Leadership Award
8. Sen. Pat Roberts Praised by AHCA, Alliance for Urging Halt to Proposed CMS Rule
9. Dr. Robert CJ Krasner Appointed to Vitals.com as Independent Advisor
10. Pioneering Heart Surgeon, Robert E. Michler, M.D., Appointed Chair of Surgery and Surgeon-in-Chief at Einstein and at Montefiore Medical Center
11. Global Action Board of Directors Announces Addition of Newest Member, Robert Hernreich
Post Your Comments:
*Name:
*Comment:
*Email:
Other Medicine News:Health News:Is There Really Such a Thing as Hope in a Jar? 2Health News:Is There Really Such a Thing as Hope in a Jar? 3Health News:Is There Really Such a Thing as Hope in a Jar? 4Health News:Is There Really Such a Thing as Hope in a Jar? 5Health News:CDC Reports Drop in Adult Smoking, But Death Toll and Health Costs Are Still Growing; Congress, States Should Implement Proven Solutions 2Health News:CDC Reports Drop in Adult Smoking, But Death Toll and Health Costs Are Still Growing; Congress, States Should Implement Proven Solutions 3Health News:CDC Reports Drop in Adult Smoking, But Death Toll and Health Costs Are Still Growing; Congress, States Should Implement Proven Solutions 4Health News:Elizabeth Edwards Reschedules Metro Detroit Appearance 2Health News:HIV Vaccine Failure Still Brings Insights 2Health News:Misonix Reports First Quarter Fiscal Year 2009 Financial Results 2Health News:Misonix Reports First Quarter Fiscal Year 2009 Financial Results 3Health News:Misonix Reports First Quarter Fiscal Year 2009 Financial Results 4Health News:Misonix Reports First Quarter Fiscal Year 2009 Financial Results 5Health News:Misonix Reports First Quarter Fiscal Year 2009 Financial Results 6Health News:Misonix Reports First Quarter Fiscal Year 2009 Financial Results 7Health News:Misonix Reports First Quarter Fiscal Year 2009 Financial Results 8Health News:Misonix Reports First Quarter Fiscal Year 2009 Financial Results 9Health News:Relationship between prostate information and lower urinary-tract symptoms evident 2
Breaking Medicine Technology:Nexavar in Combination With Chemotherapy Demonstrates Activity in Patients With Advanced Breast Cancer in Two Phase 2 Studies 2Nexavar in Combination With Chemotherapy Demonstrates Activity in Patients With Advanced Breast Cancer in Two Phase 2 Studies 3Nexavar in Combination With Chemotherapy Demonstrates Activity in Patients With Advanced Breast Cancer in Two Phase 2 Studies 4Nexavar in Combination With Chemotherapy Demonstrates Activity in Patients With Advanced Breast Cancer in Two Phase 2 Studies 5Nexavar in Combination With Chemotherapy Demonstrates Activity in Patients With Advanced Breast Cancer in Two Phase 2 Studies 6Nexavar in Combination With Chemotherapy Demonstrates Activity in Patients With Advanced Breast Cancer in Two Phase 2 Studies 7GSK Study Showed Targeted Therapy Combination Achieved 14 Month Overall Survival in Patients with Advanced Breast Cancer 2GSK Study Showed Targeted Therapy Combination Achieved 14 Month Overall Survival in Patients with Advanced Breast Cancer 3GSK Study Showed Targeted Therapy Combination Achieved 14 Month Overall Survival in Patients with Advanced Breast Cancer 4GSK Study Showed Targeted Therapy Combination Achieved 14 Month Overall Survival in Patients with Advanced Breast Cancer 5GSK Study Showed Targeted Therapy Combination Achieved 14 Month Overall Survival in Patients with Advanced Breast Cancer 6Pro-Dex, Inc. Announces Results of Annual Shareholder Meeting, an Update Regarding Major Customer's Product Development Plans, and Receipt of $1.5 Million and $3.0 Million Purchase Orders 2Pro-Dex, Inc. Announces Results of Annual Shareholder Meeting, an Update Regarding Major Customer's Product Development Plans, and Receipt of $1.5 Million and $3.0 Million Purchase Orders 3Pro-Dex, Inc. Announces Results of Annual Shareholder Meeting, an Update Regarding Major Customer's Product Development Plans, and Receipt of $1.5 Million and $3.0 Million Purchase Orders 4IMAGINE Software Unveils Advanced IMAGINEradiology 28TM 29 Features 47841 1IMAGINE Software Unveils Advanced IMAGINEradiology 28TM 29 Features 47841 2Americas Future Now Straw Poll 3A Progressives See Health Care Reform With Public Option As Top Priority 47838 1Americas Future Now Straw Poll 3A Progressives See Health Care Reform With Public Option As Top Priority 47838 2Medical Insurance Automotive and Safety Groups Call on Congress to Make This the 22Last Deadly Summer for Teens 22 by Swiftly Passing Federal Teen 47835 1Medical Insurance Automotive and Safety Groups Call on Congress to Make This the 22Last Deadly Summer for Teens 22 by Swiftly Passing Federal Teen 47835 2Medical Insurance Automotive and Safety Groups Call on Congress to Make This the 22Last Deadly Summer for Teens 22 by Swiftly Passing Federal Teen 47835 3
Other Medicine Technology:Columbia University Medical Center and Rosetta Genomics Announce Columbia University's Submission of the First Cancer Diagnostic Test Based on Rosetta Genomics Proprietary MicroRNA Technology for Approval to the New York State Department of Health Clinica 2Columbia University Medical Center and Rosetta Genomics Announce Columbia University's Submission of the First Cancer Diagnostic Test Based on Rosetta Genomics Proprietary MicroRNA Technology for Approval to the New York State Department of Health Clinica 3Columbia University Medical Center and Rosetta Genomics Announce Columbia University's Submission of the First Cancer Diagnostic Test Based on Rosetta Genomics Proprietary MicroRNA Technology for Approval to the New York State Department of Health Clinica 4Columbia University Medical Center and Rosetta Genomics Announce Columbia University's Submission of the First Cancer Diagnostic Test Based on Rosetta Genomics Proprietary MicroRNA Technology for Approval to the New York State Department of Health Clinica 5Columbia University Medical Center and Rosetta Genomics Announce Columbia University's Submission of the First Cancer Diagnostic Test Based on Rosetta Genomics Proprietary MicroRNA Technology for Approval to the New York State Department of Health Clinica 6Columbia University Medical Center and Rosetta Genomics Announce Columbia University's Submission of the First Cancer Diagnostic Test Based on Rosetta Genomics Proprietary MicroRNA Technology for Approval to the New York State Department of Health Clinica 7Senesco's Preclinical Pancreatic Islet Data to be Presented at Upcoming Conferences 2Senesco's Preclinical Pancreatic Islet Data to be Presented at Upcoming Conferences 3